Evidence map›Paper›PMID 15238604›Full record

ArticleThe Journal of experimental medicine2004

Examination of Msh6- and Msh3-deficient mice in class switching reveals overlapping and distinct roles of MutS homologues in antibody diversification.

Ziqiang Li, Stefan J Scherer, Diana Ronai, Maria D Iglesias-Ussel, Jonathan U Peled, Philip D Bardwell, Min Zhuang, KyeRyoung Lee, Alberto Martin, Winfried Edelmann and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. AID and Apobec3G haphazard deamination and mutational diversity.Cellular and molecular life sciences : CMLS · 2013
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Mismatch-mediated error prone repair at the immunoglobulin genes.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ziqiang LiDepartment of Cell Biology, Albert Einstein College of Medicine, 1300 Morris Park Ave., Chanin 403, Bronx, NY 10461, USA.
Stefan J Scherer
Diana Ronai
Maria D Iglesias-Ussel
Jonathan U Peled
Philip D Bardwell
Min Zhuang
KyeRyoung Lee
Alberto Martin
Winfried Edelmann
Matthew D Scharff
Albert Einstein College of Medicine · US

Funding

DNA MISMATCH REPAIR AND CANCER IN MURINE MODELSR01CA076329 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 1998 to 2017
$6.9M
SOMATIC MUTATION OF IG VARIABLE REGIONSR01CA072649 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1997 to 2014
$5.0M
The Role of Late MMR Proteins in DNA Repair and CancerR01CA093484 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 2002 to 2011
$3.7M
Mismatch repair in V region mutation and isotype switchingR01CA102705 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 2003 to 2013
$3.2M
MECHANISM OF ANTIBODY PROTECTION TO C NEOFORMANSR01AI043937 · NIAID · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1999 to 2003
$1.6M
NCI NIH HHS CA102705NCI NIH HHS CA72649NCI NIH HHS CA76329NCI NIH HHS CA93484NCI NIH HHS R01 CA072649NCI NIH HHS R01 CA076329NCI NIH HHS R01 CA093484NCI NIH HHS R01 CA102705NIAID NIH HHS AI43937NIAID NIH HHS R01 AI043937
6 · The paper itself

Abstract

Somatic hypermutation and class switch recombination (CSR) contribute to the somatic diversification of antibodies. It has been shown that MutS homologue (Msh)6 (in conjunction with Msh2) but not Msh3 is involved in generating A/T base substitutions in somatic hypermutation. However, their roles in CSR have not yet been reported. Here we show that Msh6(-)(/)(-) mice have a decrease in CSR, whereas Msh3(-)(/)(-) mice do not. When switch regions were analyzed for mutations, deficiency in Msh6 was associated with an increase in transition mutations at G/C basepairs, mutations at RGYW/WRCY hotspots, and a small increase in the targeting of G/C bases. In addition, Msh6(-)(/)(-) mice exhibited an increase in the targeting of recombination sites to GAGCT/GGGGT consensus repeats and hotspots in Sgamma3 but not in Smicro. In contrast to Msh2(-)(/)(-) mice, deficiency in Msh6 surprisingly did not change the characteristics of Smicro-Sgamma3 switch junctions. However, Msh6(-)(/)(-) mice exhibited a change in the positioning of Smicro and Sgamma3 junctions. Although none of these changes were seen in Msh3(-)(/)(-) mice, they had a higher percentage of large inserts in their switch junctions. Together, our data suggest that MutS homologues Msh2, Msh3, and Msh6 play overlapping and distinct roles during antibody diversification processes.

Indexed as

Immunoglobulin Class SwitchingRecombination, GeneticAnimalsAntibody DiversityBase Pair MismatchB-LymphocytesDNA-Binding ProteinsDNA Mutational AnalysisDNA RepairInterleukin-4LipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutMutS Homolog 3 ProteinProteinsDNA-Binding ProteinsInterleukin-4LipopolysaccharidesMsh3 protein, mouseMsh6 protein, mouseMutS Homolog 3 ProteinProteins

Identifiers

PMID15238604
PMCPMC2213317
OpenAlexW2159354209

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.